| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 115 |
| 1 | ADALIMUMAB | 108 |
| 2 | INTERFERON BETA-1A | 74 |
| 3 | FLUOXETINE HYDROCHLORIDE | 64 |
| 4 | DIAZEPAM | 54 |
| 5 | FOLIC ACID | 53 |
| 6 | DIAZEPAM ORAL | 52 |
| 7 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 52 |
| 8 | NICOTINE | 49 |
| 9 | NICOTINE POLACRILEX | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, .BETA.-CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | 3 | 0.0492 |
| 1 | PRENATAL SUPPLEMENT WITH DHA | 1 | 0.0227 |
| 2 | HYDROXYPROGESTERONE CAPROATE | 3 | 0.0226 |
| 3 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 5 | 0.0095 |
| 4 | FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT | 1 | 0.0051 |
| 5 | CHORIONIC GONADOTROPIN | 2 | 0.0036 |
| 6 | CLOMIPHENE CITRATE | 5 | 0.0033 |
| 7 | NAFCILLIN SODIUM | 3 | 0.0033 |
| 8 | BROMOCRIPTINE MESYLATE | 2 | 0.0031 |
| 9 | METHYLDOPA | 15 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 126 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 76 |
| 2 | Interferon beta [EPC] | 74 |
| 3 | Benzodiazepine [EPC] | 69 |
| 4 | Vitamin C [EPC] | 58 |
| 5 | Vitamin B12 [EPC] | 56 |
| 6 | Vitamin D [EPC] | 56 |
| 7 | Cholinergic Nicotinic Agonist [EPC] | 49 |
| 8 | Corticosteroid [EPC] | 49 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 49 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 7 | 0.0023 |
| 1 | Opioid Antagonist [EPC] | 2 | 0.0021 |
| 2 | Cholinergic Nicotinic Agonist [EPC] | 49 | 0.0008 |
| 3 | Progesterone [EPC] | 15 | 0.0006 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 3 | 0.0004 |
| 6 | Interferon beta [EPC] | 74 | 0.0004 |
| 7 | Prostaglandin E1 Analog [EPC] | 6 | 0.0004 |
| 8 | Protease Inhibitor [EPC] | 16 | 0.0004 |
| 9 | Partial Opioid Agonist [EPC] | 28 | 0.0003 |